The role of mTOR inhibitors in the treatment of hepatocellular carcinoma.
Huang, Yi-Hsiang
The role of mTOR inhibitors in the treatment of hepatocellular carcinoma. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver Sep 2013 - 1133-4 p. digital
Publication Type: Editorial; Comment
1478-3231
10.1111/liv.12213 doi
Aminopyridines--pharmacology
Carcinoma, Hepatocellular--drug therapy
Humans
Imidazoles--pharmacology
Liver Neoplasms--drug therapy
Morpholines--pharmacology
Phosphoinositide-3 Kinase Inhibitors
Quinolines--pharmacology
Sirolimus--analogs & derivatives
TOR Serine-Threonine Kinases--antagonists & inhibitors
The role of mTOR inhibitors in the treatment of hepatocellular carcinoma. [electronic resource] - Liver international : official journal of the International Association for the Study of the Liver Sep 2013 - 1133-4 p. digital
Publication Type: Editorial; Comment
1478-3231
10.1111/liv.12213 doi
Aminopyridines--pharmacology
Carcinoma, Hepatocellular--drug therapy
Humans
Imidazoles--pharmacology
Liver Neoplasms--drug therapy
Morpholines--pharmacology
Phosphoinositide-3 Kinase Inhibitors
Quinolines--pharmacology
Sirolimus--analogs & derivatives
TOR Serine-Threonine Kinases--antagonists & inhibitors